Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 91651-91700 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03482986
Role of Dietary Habits in Efficacy of Bariatric Surgery - Study C
NA
Active, not recruiting
44 participants
Started: Dec 7, 2021 · Completed: May 31, 2025
3 conditions
2 sponsors
1 location
NCT04982757
Accelerated TMS for Depression and OCD
NA
Recruiting
500 participants
Started: Dec 7, 2021 · Completed: Aug 31, 2026
2 conditions
4 sponsors
1 location
NCT05097534
A Comprehensive Community Approach for Diabetes Prevention and Care for a Vulnerable Population in Galveston
NA
Enrolling by invitation
150 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05423028
Vitamin B12 and Dextrose for Median Nerve Hydrodissection
NA
Recruiting
120 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05014139
A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
PHASE1
Recruiting
58 participants
Started: Dec 7, 2021 · Completed: May 31, 2028
5 conditions
2 sponsors
32 locations
NCT05153252
Timing Intervention of Morning Versus Evening Exercise
NA
Recruiting
128 participants
Started: Dec 7, 2021 · Completed: Mar 31, 2027
1 condition
2 sponsors
1 location
NCT06814925
Italian Study of Patients With Lymphoma
N/A
Recruiting
1,500 participants
Started: Dec 7, 2021 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT04784052
Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab
PHASE1/PHASE2
Recruiting
12 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT04976127
Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients
PHASE1
Active, not recruiting
22 participants
Started: Dec 7, 2021 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT04997902
Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
PHASE1/PHASE2
Active, not recruiting
40 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
11 locations
NCT04995003
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
PHASE1
Recruiting
25 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2040
8 conditions
7 sponsors
1 location
NCT04059640
PMCF Study of LiquiBand FIX8® OHMF Device
NA
Active, not recruiting
109 participants
Started: Dec 7, 2021 · Completed: Jul 31, 2026
1 condition
2 sponsors
3 locations
NCT05072600
Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer
PHASE2
Recruiting
54 participants
Started: Dec 7, 2021 · Completed: Nov 1, 2029
5 conditions
1 sponsor
1 location
NCT05023486
NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies
PHASE1/PHASE2
Recruiting
140 participants
Started: Dec 7, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
18 locations
NCT05156749
Short and Long-arm Fiberglass Cast Immobilization for Distal Salter Harris I and II Forearm Fractures in Children
NA
Recruiting
120 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05020457
SI-B001 Combined With Chemotherapy in the Treatment of EGFR/ALK WT Recurrent or Metastatic NSCLC.
PHASE2
Active, not recruiting
69 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
6 locations
NCT05027425
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
PHASE2
Active, not recruiting
30 participants
Started: Dec 7, 2021 · Completed: Dec 7, 2030
3 conditions
1 sponsor
3 locations
NCT05622669
Understanding Patterns of Fatigue in Health and Disease
N/A
Active, not recruiting
40 participants
Started: Dec 7, 2021 · Completed: Mar 30, 2024
3 conditions
6 sponsors
1 location
NCT04930107
Vulvovaginal Candidiasis in Canadian Females
EARLY_PHASE1
Recruiting
105 participants
Started: Dec 7, 2021 · Completed: Apr 30, 2026
1 condition
3 sponsors
1 location
NCT04285242
Metabolic and Immunological Phenotyping in Patients With Cancer
N/A
Recruiting
80 participants
Started: Dec 7, 2021 · Completed: Jun 1, 2024
2 conditions
1 sponsor
2 locations
NCT05154825
Evaluating and Establishing the Relationship in the Five Critical X-ray Time Points in Spinal Deformity Realignment
N/A
Recruiting
40 participants
Started: Dec 7, 2021 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT04735627
Real-Time Levodopa Level Monitoring in Parkinson Disease
NA
Recruiting
20 participants
Started: Dec 7, 2021 · Completed: Feb 29, 2028
1 condition
1 sponsor
1 location
NCT04994665
Evaluation of Omentopexy on Gastro-oesophageal Reflux Following Sleeve Gastrectomy
NA
Recruiting
526 participants
Started: Dec 7, 2021 · Completed: Nov 1, 2028
1 condition
1 sponsor
9 locations
NCT05077904
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
PHASE3
Recruiting
350 participants
Started: Dec 7, 2021 · Completed: Apr 6, 2026
1 condition
1 sponsor
174 locations
NCT07039331
Short-term Fasting Compared to Free Diet on Ovarian Cancer Patients
NA
Recruiting
54 participants
Started: Dec 7, 2021 · Completed: Aug 1, 2026
1 condition
1 sponsor
1 location
NCT05117775
Towards A Better Paradigm for Head and Neck Cancer Treatment Applying Artificial Intelligence. HNC-TACTIC.
N/A
Recruiting
10,000 participants
Started: Dec 6, 2021 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT05738421
Tracheal Tube and Swallowing After Head and Neck Surgery
N/A
Recruiting
30 participants
Started: Dec 6, 2021 · Completed: Oct 6, 2026
1 condition
1 sponsor
1 location
NCT05142293
One Day Implantation Program for Heart Failure Patients Implanted With CRT-P
N/A
Recruiting
436 participants
Started: Dec 6, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
22 locations
NCT05136846
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer
PHASE1
Recruiting
28 participants
Started: Dec 6, 2021 · Completed: Dec 31, 2026
9 conditions
2 sponsors
2 locations
NCT05050084
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
PHASE3
Recruiting
2,050 participants
Started: Dec 6, 2021 · Completed: Nov 11, 2026
1 condition
2 sponsors
570 locations
NCT04852328
Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma
PHASE2
Recruiting
30 participants
Started: Dec 6, 2021 · Completed: Oct 31, 2027
1 condition
2 sponsors
1 location
NCT05066061
Virtual Reality and Peripheral Intravenous Catheter Insertion to Children (R3VP)
NA
Recruiting
210 participants
Started: Dec 6, 2021 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT05196984
Gamma Frequency Stimulation in Individuals With Down Syndrome
NA
Recruiting
60 participants
Started: Dec 6, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04826224
CAM Procedure With BMAC for Shoulder OA
PHASE1
Active, not recruiting
12 participants
Started: Dec 6, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05008809
Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
PHASE3
Recruiting
507 participants
Started: Dec 6, 2021 · Completed: Nov 30, 2030
1 condition
3 sponsors
79 locations
NCT04823923
Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer
NA
Recruiting
60 participants
Started: Dec 6, 2021 · Completed: Mar 31, 2026
1 condition
2 sponsors
5 locations
NCT05034497
Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
PHASE1
Active, not recruiting
18 participants
Started: Dec 6, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
6 locations
NCT04996121
A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors
PHASE1/PHASE2
Recruiting
360 participants
Started: Dec 6, 2021 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT05145010
Extension Study of Infigratinib in Children With Achondroplasia (ACH)
PHASE2
Enrolling by invitation
300 participants
Started: Dec 6, 2021 · Completed: Feb 1, 2032
1 condition
1 sponsor
29 locations
NCT04838717
Clinical Trial of Doxycycline VS BPG for Early Syphilis (SY-DOXY)
PHASE3
Active, not recruiting
200 participants
Started: Dec 6, 2021 · Completed: Aug 3, 2025
1 condition
1 sponsor
7 locations
NCT04922762
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 2
NA
Recruiting
360 participants
Started: Dec 6, 2021 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT04597671
Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)
PHASE3
Active, not recruiting
170 participants
Started: Dec 6, 2021 · Completed: Dec 31, 2032
1 condition
1 sponsor
14 locations
NCT04821284
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
PHASE1/PHASE2
Recruiting
120 participants
Started: Dec 6, 2021 · Completed: Feb 28, 2026
8 conditions
2 sponsors
2 locations
NCT04207437
Daily Hand-Held Vibration Therapy
NA
Recruiting
16 participants
Started: Dec 6, 2021 · Completed: Jan 31, 2026
4 conditions
2 sponsors
3 locations
NCT05177432
Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer
PHASE1
Recruiting
26 participants
Started: Dec 6, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05215106
Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)
PHASE2
Recruiting
200 participants
Started: Dec 6, 2021 · Completed: Jun 30, 2026
1 condition
2 sponsors
3 locations
NCT05368207
Pembrolizumab in Small Cell Carcinoma of Ovary - Hypercalcemic Type Patient
NA
Active, not recruiting
1 participants
Started: Dec 6, 2021 · Completed: Nov 2, 2024
2 conditions
1 sponsor
1 location
NCT05239338
Preserving Fertility After Colorectal Cancer Study
N/A
Recruiting
1,000 participants
Started: Dec 6, 2021 · Completed: Dec 31, 2037
1 condition
1 sponsor
1 location
NCT04559217
68Ga-DOTATATE Neuroblastoma Imaging Pilot
PHASE2
Recruiting
20 participants
Started: Dec 6, 2021 · Completed: Sep 30, 2027
1 condition
1 sponsor
3 locations
NCT04259411
MitraClip China PMS
NA
Active, not recruiting
51 participants
Started: Dec 6, 2021 · Completed: May 31, 2025
1 condition
1 sponsor
5 locations
Previous
1
More pages
1831
1832
1833
1834
1835
1836
1837
More pages
2369
Next